BlackRock’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
1,140,592
-3,804
| -0.3% | -$4.03K | ﹤0.01% | 4124 |
|
|
2025
Q1 | $1.25M | Sell |
1,144,396
-2,088
| -0.2% | -$2.28K | ﹤0.01% | 4085 |
|
|
2024
Q4 | $1.73M | Buy |
1,146,484
+1,687
| +0.1% | +$2.55K | ﹤0.01% | 4019 |
|
|
2024
Q3 | $1.71M | Sell |
1,144,797
-17,396
| -1% | -$25.9K | ﹤0.01% | 3994 |
|
|
2024
Q2 | $1.88M | Sell |
1,162,193
-1,948,116
| -63% | -$3.16M | ﹤0.01% | 3933 |
|
|
2024
Q1 | $5.29M | Sell |
3,110,309
-119,488
| -4% | -$203K | ﹤0.01% | 3596 |
|
|
2023
Q4 | $10M | Sell |
3,229,797
-1,366,581
| -30% | -$4.24M | ﹤0.01% | 3326 |
|
|
2023
Q3 | $28.2M | Sell |
4,596,378
-80,650
| -2% | -$495K | ﹤0.01% | 2697 |
|
|
2023
Q2 | $29.3M | Buy |
4,677,028
+646,859
| +16% | +$4.05M | ﹤0.01% | 2735 |
|
|
2023
Q1 | $19.2M | Buy |
4,030,169
+578,802
| +17% | +$2.76M | ﹤0.01% | 2938 |
|
|
2022
Q4 | $30M | Buy |
3,451,367
+91,044
| +3% | +$792K | ﹤0.01% | 2761 |
|
|
2022
Q3 | $40M | Buy |
3,360,323
+2,179
| +0.1% | +$25.9K | ﹤0.01% | 2589 |
|
|
2022
Q2 | $47.9M | Buy |
3,358,144
+717,794
| +27% | +$10.2M | ﹤0.01% | 2498 |
|
|
2022
Q1 | $55M | Buy |
2,640,350
+100,526
| +4% | +$2.09M | ﹤0.01% | 2492 |
|
|
2021
Q4 | $58.7M | Buy |
2,539,824
+351,901
| +16% | +$8.13M | ﹤0.01% | 2515 |
|
|
2021
Q3 | $65.2M | Buy |
2,187,923
+269,789
| +14% | +$8.04M | ﹤0.01% | 2462 |
|
|
2021
Q2 | $65.5M | Buy |
1,918,134
+492,261
| +35% | +$16.8M | ﹤0.01% | 2488 |
|
|
2021
Q1 | $46.9M | Buy |
1,425,873
+80,858
| +6% | +$2.66M | ﹤0.01% | 2618 |
|
|
2020
Q4 | $82.7M | Buy |
1,345,015
+802,977
| +148% | +$49.4M | ﹤0.01% | 2162 |
|
|
2020
Q3 | $19.2M | Buy |
+542,038
| New | +$19.2M | ﹤0.01% | 2809 |
|